Products of the ghrelin gene, the pancreatic β-cell and the adipocyte

Endocrine Development

Volumn 25, Issue , 2013, Pages 144-156

  Granata, Riccarda ^a   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; GHRELIN; GHRELIN O ACYLTRANSFERASE; GHRELIN RECEPTOR; GROWTH HORMONE SECRETAGOGUE; OBESTATIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; ENERGY METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 84877974356     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000346306     Document Type: Article

References (86)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. van der Lely AJ, Tschop M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25: 426-457.
3. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE: Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-6325.
4. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL: Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008; 132: 387-396.
5. Sun Y, Wang P, Zheng H, Smith RG: Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679-4684.
6. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S: Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-129.
7. Dezaki K, Hosoda H, Kakei M, Hashiguchi S, Watanabe M, Kangawa K, Yada T: Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca 2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 2004; 53: 3142-3151.
8. Gnanapavan S, Kola B, Bustin SA, Morris DG, Mc-Gee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988.
9. Kos K, Harte AL, O'Hare PJ, Kumar S, McTernan PG: Ghrelin and the differential regulation of desacyl (DSG) and oct-anoyl ghrelin (OTG) in human adipose tissue (AT). Clin Endocrinol (Oxf) 2009; 70: 383-389.
10. Gurriaran-Rodriguez U, Al-Massadi O, Crujeiras AB, Mosteiro CS, Amil-Diz M, Beiroa D, Nogueiras R, Seoane LM, Gallego R, Pazos Y, Casanueva FF, Camina JP: Preproghrelin expression is a key target for insulin action on adipogenesis. J Endocrinol 2011; 210:R1-7.
11. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K: Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem 2003; 278: 64-70.
12. Granata R, Settanni F, Biancone L, Trovato L, Nano R, Bertuzzi F, Destefanis S, Annunziata M, Martinetti M, Catapano F, Ghe C, Isgaard J, Papotti M, Ghigo E, Muccioli G: Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3 ' ,5 ' -cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-kinase/Akt signaling. Endocrinology 2007; 148: 512-529.
13. Muccioli G, Baragli A, Granata R, Papotti M, Ghigo E: Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology 2007; 86: 147-164.
14. Benso A, St-Pierre DH, Prodam F, Gramaglia E, Granata R, van der Lely AJ, Ghigo E, Broglio F: Metabolic effects of overnight continuous infusion of unacylated ghrelin in humans. Eur J Endocrinol 2012; 166: 911-916.
15. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A: Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-1037.
16. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ: Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
17. Zhang JV, Jahr H, Luo CW, Klein C, Van Kolen K, Ver Donck L, De A, Baart E, Li J, Moechars D, Hsueh AJ: Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol Endocrinol 2008; 22: 1464-1475.
18. Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, Audinot V, Chomarat P, Coge F, Nosjean O, Rodriguez M, Galizzi JP, Boutin JA, Vaudry H, Llorens-Cortes C: Comment on 'Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake'. Science 2007; 315: 766; author reply 766.
19. Tremblay F, Perreault M, Klaman LD, Tobin JF, Smith E, Gimeno RE: Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 2007; 148: 501-506.
20. Gronberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J: Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 2008; 56: 793-801.
21. Granata R, Settanni F, Gallo D, Trovato L, Biancone L, Cantaluppi V, Nano R, Annunziata M, Campiglia P, Arnoletti E, Ghe C, Volante M, Papotti M, Muccioli G, Ghigo E: Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008; 57: 967-979.
22. Miegueu P, St Pierre D, Broglio F, Cianflone K: Effect of desacyl ghrelin, obestatin and related peptides on triglyceride storage, metabolism and GHSR signaling in 3T3-L1 adipocytes. J Cell Biochem 2011; 112: 704-714.
23. Granata R, Gallo D, Luque RM, Baragli A, Scarlatti F, Grande C, Gesmundo I, Crdoba-Chacn J, Bergandi L, Settanni F, Togliatto G, Volante M, Garetto S, Annunziata M, Chancln B, Gargantini E, Rocchietto S, Matera L, Datta G, Morino M, Brizzi MF, Ong H, Camussi G, Castaño JP, Papotti M, Ghigo E: Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation. FASEB J 2012; 26: 3393-3411.
24. Gurriaran-Rodriguez U, Al-Massadi O, Roca-Rivada A, Crujeiras AB, Gallego R, Pardo M, Seoane LM, Pazos Y, Casanueva FF, Camina JP: Obestatin as a regulator of adipocyte metabolism and adipogenesis. J Cell Mol Med 2011; 15: 1927-1940.
25. Dezaki K, Sone H, Koizumi M, Nakata M, Kakei M, Nagai H, Hosoda H, Kangawa K, Yada T: Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006; 55: 3486-3493.
26. Kageyama H, Funahashi H, Hirayama M, Takenoya F, Kita T, Kato S, Sakurai J, Lee EY, Inoue S, Date Y, Nakazato M, Kangawa K, Shioda S: Morphological analysis of ghrelin and its receptor distribution in the rat pancreas. Regul Pept 2005; 126: 67-71.
27. Chanoine JP, Wong AC: Ghrelin gene expression is markedly higher in fetal pancreas compared with fetal stomach: effect of maternal fasting. Endocrinology 2004; 145: 3813-3820.
28. Wierup N, Svensson H, Mulder H, Sundler F: The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
29. Andralojc KM, Mercalli A, Nowak KW, Albarello L, Calcagno R, Luzi L, Bonifacio E, Doglioni C, Piemonti L: Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 2009; 52: 486-493.
30. Wierup N, Yang S, McEvilly RJ, Mulder H, Sundler F: Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 2004; 52: 301-310.
31. Hill JT, Mastracci TL, Vinton C, Doyle ML, Anderson KR, Loomis ZL, Schrunk JM, Minic AD, Prabakar KR, Pugliese A, Sun Y, Smith RG, Sussel L: Ghrelin is dispensable for embryonic pancreatic islet development and differentiation. Regul Pept 2009; 157: 51-56.
32. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L: Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 2004; 101: 2924-2929.
33. Adeghate E, Ponery AS: Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 2002; 14: 555-560.
34. Portela-Gomes GM, Johansson H, Olding L, Grimelius L: Co-localization of neuroendocrine hormones in the human fetal pancreas. Eur J Endocrinol 1999; 141: 526-533.
35. Vignjevic S, Todorovic V, Damjanovic S, Budec M, Mitrovic O, Djikic D, Drndarevic N, Micic M, Miskovic-Krivokapic J, Djuricic S, Nikolic I: Similar developmental patterns of ghrelin- and glucagon-expressing cells in the human pancreas. Cells Tissues Organs 2012.
36. Hasselby JP, Maroun LL, Federspiel BH, Vainer B: Ghrelin in the fetal pancreas - a digital quantitation study. APMIS 2012; 120: 157-166.
37. Walia P, Asadi A, Kieffer TJ, Johnson JD, Chanoine JP: Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr Res 2009; 65: 39-44.
38. Granata R, Baragli A, Settanni F, Scarlatti F, Ghigo E: Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 2010; 45: 107-118.
39. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S: Expression of ghrelin and its receptor in human tissues. Horm Metab Res 2009; 41: 814-821.
40. Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, Wiedenmann B, Settanni F, Granata R, Papotti M: Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 2009; 218: 458-466.
41. Zhao CM, Furnes MW, Stenstrom B, Kulseng B, Chen D: Characterization of obestatin- and ghrelinproducing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electronmicroscopic study. Cell Tissue Res 2008; 331: 575-587.
42. Briggs DI, Andrews ZB: A recent update on the role of ghrelin in glucose homeostasis. Curr Diabetes Rev 2011; 7: 201-207.
43. Stengel A, Tache Y: Ghrelin - a pleiotropic hormone secreted from endocrine x/a-like cells of the stomach. Front Neurosci 2012; 6: 24.
44. Filigheddu N, Gnocchi VF, Coscia M, Cappelli M, Porporato PE, Taulli R, Traini S, Baldanzi G, Chianale F, Cutrupi S, Arnoletti E, Ghe C, Fubini A, Surico N, Sinigaglia F, Ponzetto C, Muccioli G, Crepaldi T, Graziani A: Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007; 18: 986-994.
45. Granata R, Settanni F, Trovato L, Destefanis S, Gallo D, Martinetti M, Ghigo E, Muccioli G: Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells. J Endocrinol Invest 2006; 29:RC19-RC22.
46. Mandrup-Poulsen T: Beta-cell apoptosis: stimuli and signaling. Diabetes 2001; 50(suppl 1):S58-S63.
47. Muccioli G, Pons N, Ghe C, Catapano F, Granata R, Ghigo E: Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004; 498: 27-35.
48. McCabe C, Samali A, O'Brien T: beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS. Biochem Biophys Res Commun 2006; 342: 1240-1248.
49. Zhang Y, Ying B, Shi L, Fan H, Yang D, Xu D, Wei Y, Hu X, Zhang Y, Zhang X, Wang T, Liu D, Dou L, Chen G, Jiang F, Wen F: Ghrelin inhibit cell apoptosis in pancreatic beta cell line HIT-T15 via mitogenactivated protein kinase/phosphoinositide 3-kinase pathways. Toxicology 2007; 237: 194-202.
50. Wang W, Liu Y, Chen Y, Cao C, Xiang Y, Zhang D, Han L, Zhao H, Liu G: Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic beta-cells. Peptides 2010; 31: 307-314.
51. Wang W, Zhang D, Zhao H, Chen Y, Liu Y, Cao C, Han L, Liu G: Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic beta-cell line. Regul Pept 2010; 161: 43-50.
52. Granata R, Settanni F, Julien M, Nano R, Togliatto G, Trombetta A, Gallo D, Piemonti L, Brizzi MF, Abribat T, van Der Lely AJ, Ghigo E: Des-acyl ghrelin fragments and analogues promote survival of pancreatic beta-cells and human pancreatic islets and prevent diabetes in streptozotocin-treated rats. J Med Chem 2012; 55: 2585-2596.
53. Egido EM, Hernandez R, Marco J, Silvestre RA: Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2008.
54. Tremblay F, Richard AM, Will S, Syed J, Stedman N, Perreault M, Gimeno RE: Disruption of G proteincoupled receptor 39 impairs insulin secretion in vivo. Endocrinology 2009; 150: 2586-2595.
55. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M: cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 2003; 17: 1575-1580.
56. Cheng H, Straub SG, Sharp GW: Inhibitory role of Src family tyrosine kinases on Ca2+-dependent insulin release. Am J Physiol Endocrinol Metab 2007; 292:E845-E852.
57. Favaro E, Granata R, Miceli I, Baragli A, Settanni F, Cavallo Perin P, Ghigo E, Camussi G, Zanone MM: The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways. Diabetologia 2012; 55: 1058-1070.
58. Irako T, Akamizu T, Hosoda H, Iwakura H, Ariyasu H, Tojo K, Tajima N, Kangawa K: Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 2006; 49: 1264-1273.
59. Yamamoto H, Uchigata Y, Okamoto H: Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 1981; 294: 284-286.
60. Ceranowicz P, Warzecha Z, Dembinski A, Cieszkowski J, Dembinski M, Sendur R, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I: Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J Physiol Pharmacol 2009; 60: 95-101.
61. Warzecha Z, Ceranowicz P, Dembinski A, Cieszkowski J, Kusnierz-Cabala B, Tomaszewska R, Kuwahara A, Kato I: Therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis in rats. J Physiol Pharmacol 2010; 61: 419-427.
62. Kerem M, Salman B, Ozsoy S, Pasaoglu H, Bedirli A, Haziroglu R, Yilmaz TU: Exogenous ghrelin enhances endocrine and exocrine regeneration in pancreatectomized rats. J Gastrointest Surg 2009; 13: 775-783.
63. Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
64. Soares VM, Garcia-Souza EP, Lacerda-Miranda G, Moura AS: Early life overfeeding decreases acylated ghrelin circulating levels and upregulates GHSR1a signaling pathway in white adipose tissue of obese young mice. Regul Pept 2012; 174: 6-11.
65. Kim MS, Yoon CY, Jang PG, Park YJ, Shin CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, Kim SY, Lee HK, Kim YB, Park KS: The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18: 2291-2301.
66. Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, Kojima M, Kangawa K, Sasaki S: The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003; 144: 754-759.
67. Patel AD, Stanley SA, Murphy KG, Frost GS, Gardiner JV, Kent AS, White NE, Ghatei MA, Bloom SR: Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Pept 2006; 134: 17-22.
68. Davies JS, Kotokorpi P, Eccles SR, Barnes SK, Tokarczuk PF, Allen SK, Whitworth HS, Guschina IA, Evans BA, Mode A, Zigman JM, Wells T: Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol 2009; 23: 914-924.
69. Rodriguez A, Gomez-Ambrosi J, Catalan V, Gil MJ, Becerril S, Sainz N, Silva C, Salvador J, Colina I, Fruhbeck G: Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) 2009; 33: 541-552.
70. Fontenot E, DeVente JE, Seidel ER: Obestatin and ghrelin in obese and in pregnant women. Peptides 2007; 28: 1937-1944.
71. Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, Mulholland MW: Inhibition of adipogenesis by ghrelin. Mol Biol Cell 2004; 15: 2484-2491.
72. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
73. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR: Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540-2547.
74. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schurmann A, Szanto I, Tschop MH, Rohner-Jeanrenaud F: Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006; 116: 1983-1993.
75. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T: Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004; 145: 234-242.
76. Perez-Tilve D, Heppner K, Kirchner H, Lockie SH, Woods SC, Smiley DL, Tschop M, Pfluger P: Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J 2011; 25: 2814-2822.
77. Zhang W, Chai B, Li JY, Wang H: Mulholland MW: Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008; 149: 4710-4716.
78. Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WF, Swagemakers S, Smith RG, Themmen AP, van der Lely AJ: Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS ONE 2010; 5:e11749
79. Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H: Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regul Pept 2005; 130: 97-103.
80. Ott V, Fasshauer M, Dalski A, Meier B, Perwitz N, Klein HH, Tschop M, Klein J: Direct peripheral effects of ghrelin include suppression of adiponectin expression. Horm Metab Res 2002; 34: 640-645.
81. Mano-Otagiri A, Ohata H, Iwasaki-Sekino A, Nemoto T, Shibasaki T: Ghrelin suppresses noradrenaline release in the brown adipose tissue of rats. J Endocrinol 2009; 201: 341-349.
82. Giovambattista A, Piermaria J, Suescun MO, Calandra RS, Gaillard RC, Spinedi E: Direct effect of ghrelin on leptin production by cultured rat white adipocytes. Obesity (Silver Spring) 2006; 14: 19-27.
83. Lin L, Saha PK, Ma X, Henshaw IO, Shao L, Chang BH, Buras ED, Tong Q, Chan L, McGuinness OP, Sun Y: Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011; 10: 996-1010
84. Baragli A, Ghe C, Arnoletti E, Granata R, Ghigo E, Muccioli G: Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase gamma and phosphodiesterase 3B. Biochim Biophys Acta 2011; 1811: 386-396.
85. Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N, Jorgensen JO: Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of GH-signaling. Diabetes 2008; 12: 3205.
86. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR, Olefsky JM: SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29: 1363-1374.